China丨Lansheng’s subsidiary company to invest ¥51 million in production line reconstructions, including 1000T/A Clethodim technical
On Oct 17, the acceptance of environmental assessment for the reconstruction of production lines of technicals and adjuvant and upgrading of environmental protection facilities of Lanrun was published on the website.
Lanrun plans to invest ¥51.364 million in the project of production line reconstruction of technicals and adjuvant and the upgrade and transformation of environmental protection facilities.
The main construction include:
(1) maintain the current production capacity, technically reconstruct the annual production of 1000T/A Clethodim technical, 2000T/A Clethodim TK, 100T/A Sethoxydim technical;
(2) to eliminate the existing annual production of 2000T/A Metribuzin technical, 300T/A Haloxyfop-methyl technical, 200T/A Cyazofamid technical, 100T/A Picoxystrobin technical and 100T/A Flonicamid technical;
(3) maintain the current production capacity, technically reconstruct the annual output of 300T/A Isoxadifen-ethyl adjuvant;
(4) maintain the current production capacity, technically reconstruct the annual production of 500T/A Spirotetramat technical and matched with the raw material of 2,5-dimethylphenyl)acetyl chloride for the production of Spirotetramat;
(5) maintain the current production capacity, technically reconstruct the annual output of 120g/L Clethodim EC with an annual output of 500T/A and 240g/L Clethodim EC with an annual output of 900t/a.
After the completion of the project, the product types of the whole factory are Clethodim technical, Clethodim TK, Sethoxydim technical, Spirotetramat technical, Isoxadifen-ethyl adjuvant and 120g/L, 240g/L Clethodim EC。
Established on April 17, 2014, Lanrun is a wholly-owned subsidiary of Lansheng Biotech. Its business scope includes scientific and technological research and extension services of plant protection technology, production and sales of pesticides and medicine pesticide intermediates, 2-Chloro-5-(chloromethyl)pyridine and related chemical raw materials production. Established in 2014, Lansheng Biotech is a designated pesticide enterprise focusing on green chemistry innovation. Its core products include Clethodim, Spirotetramat Metribuzin, Brassinolide and Boscalid.
2026-08-22
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
BASF's Agrochemicals Division Is Preparing to Raise Funds for Listing in the United States or Germany
-
China approved the registration of pea field's first herbicide product
-
Agri Tech(India) will be held in Bangalore from August 22-24
-
The Brazilian market for biological inputs for the 2022-2023 planting season grew by 52%
-
Rainbow invested ¥2.68 billion in technical production and new projects including Clethodim, 2, 4-D and Flumioxazin
-
Thiamethoxam is again approved for sale, use, production and import in Brazil
-
Deepak Group in India launched its first fluorine chemical plant and officially set foot in the field of fluorine chemistry
-
China agrochemical industry weekly(0119)
-
CYNDA(Liaoning) plans to expand the technical project of 5000 t/a Clethodim
-
China agrochemical industry weekly(0112)
Recommend Reading
-
BASF Battles Market Turmoil as Profits Slide
-
Merck Establishes New Semiconductor Hub in Taiwan
-
Eurofragance Opens New Creative Center in Jakarta to Expand Its Asian Footprint
-
Another Strategic Move! DuPont Launches a New Specialty Lubricants Project in Zhangjiagang
-
A Comprehensive Overview of China’s Special Engineering Materials Market: How Should the Industry Rebuild Its Capabilities Amid Growing Downstream Pressure?
-
Business Society’s Market Outlook for Acetic Acid on August 11, 2026: Volatile and Tending to Weaken
-
Potassium Hydroxide (KOH): Soap Making, Batteries, and Safety
-
Premium Global Chemical Sourcing Requests (23 - 27 Feb, 2026)
-
What Color Should a Zinc-Copper Couple Be?
-
Understanding Titanium Oxide: Properties and Uses